Conventional Chondrosarcoma research hub

Study of INBRX-109 in Conventional Chondrosarcoma

This study is testing a new medicine, INBRX-109, for people with a type of bone cancer called conventional chondrosarcoma that has spread or can't be removed by surgery. It compares the new medicine to a dummy treatment (placebo) to see if it's safe and effective.